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The rationale
Fiscal, legislative and regulatory interventions now comprise themain WHO recommended ‘best-buys’ for preventing and
controlling non-communicable diseases (NCDs). Yet these interven-
tions are not well-suited to rigorous study using clinical trials, as
they are often not feasible or ethical outside of smaller pilot studies.
Currently we estimate that <1 out of every 10 NCD interventions are
subject to real-world evaluation, including actions to ban trans-fat,
tobacco control measures in the Framework Convention on Tobacco
Control, alcohol minimum pricing and sugar-sweetened beverage
taxes.1 This lack of impact evaluation obviates learning from what
works, where and why. Without evidence it may also render these
programmes more vulnerable to challenges from vested interests
who seek to oppose them.
To begin addressing these challenges and improving the science of
implementation,2,3 recent epidemiological advances have started to take
advantage of the opportunity to evaluate policy implementation as a so-
called ‘natural experiment’. Here, what differs from a randomized trial
is that the intervention is not within the control of the research team
but can be evaluated ‘as if’ it were an experiment. Importantly, this pays
critical attention to developing a ‘control group’, which was not exposed
to the intervention but is otherwise similar. A suite of methods have
been developed to enable researchers and public health professionals to
build context-appropriate evidence-based on rigorous designs regarding
the impact of policies attempting to address NCDs, including regression
adjustment, propensity scores, difference-in-differences, interrupted
time series and synthetic controls.4 In light of these methodological
developments, the UK Medical Research Council now recommends
natural experiment designs for evaluating population health
interventions.4
Many examples of natural experiments now exist in the scientific
literature, from evaluating the impact of free-trade agreements on
sugar-sweetened beverage consumption,5 to the impact of reducing
housing benefit on mental health.6 Yet a gap remains in the uptake
of these methods by practitioners working in health ministries.
Often the methods employed in these settings involve simple de-
scriptive statistics without giving careful consideration to techniques
that can strengthen evaluation, such as constructing a control group
or a clear ‘counterfactual’, identifying what would have happened
absent the intervention.
To address this gap in real-world practice, we launched the WHO
Regional Office for Europe’s (WHO/Europe) Natural Experiment
Studies Project—an exercise in deploying these methods to begin
the process of building a more influential evidence-base for the
control of NCDs. This series presents four studies that were
produced by national research teams as a result of the first
iteration of this exercise.
WHO natural experiment course in Copenhagen
In March 2017, WHO/Europe invited the Ministries of Health from
eight countries from across the WHO European Region7—Austria,
Finland, Hungary, Norway, Romania, Russian Federation, Turkey
and Ukraine—to each nominate a public health research team (of
two or three people) to attend a workshop at the WHO Regional
Office in Copenhagen. To try and ensure the overall process would
have both academic rigour and public health relevance we asked that
the teams be made of a mix of health policy and academic experts.
There were 20 participants in all.
The workshop presented the principles and application of natural
experiment study techniques and was facilitated by David Stuckler
and Aaron Reeves, and supported by external experts—Matthias
Rieger, Galina Sakharova, Konstantin Vyshinskiy and Andrew
Snell—and by experts from WHO/Europe. To participate, we
invited research teams to identify a priority national population
health intervention for NCD control and potential sources of data,
and to commit to undertaking a natural experiment study. By the
end of the two day workshop, the eight teams had developed a study
design to proceed with.
During the following 14 months we provided support to the
country teams, facilitating the design, data collection, analysis and
drafting and editing of manuscripts. We also offered up to US$5000
of funding per team as needed, to get the study off the ground and
for a suitable data analysis and statistical software licence. As had
been anticipated from the outset, some teams were unable to
progress to a final study. This happened for a variety of reasons:
 The process depended on collaboration within the team and with
the experts, so any tension in priorities made it hard to
proceed—in some cases studies were being dictated by the
agenda of a short-term policy priority even if the policy was
not amenable to evaluation using these methodologies;
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 The teams were quite small, so there was little resilience to any
reduction in capacity—changes or restructures in the ministries
and in the academic institutions of some of the team members
resulted in conflicting time-demands;
 The study methodologies being presented were very new to some
research teams, and so any barriers to learning these made
progress with remote support more difficult—barriers included
conflicting time-demands, language and the baseline expertise of
team members;
 Whilst the methods presented use mainly secondary data, there
still needs to be a certain quality and detail in the data to make
the analysis worthwhile—many of the studies suffered from a
lack of consistent data covering a long enough time period, a
lack of data on potential confounders and difficulty getting
adequate data from comparator countries.
One recurring challenge facing the teams was the ability to
identify a suitable ‘control group’. This marked a major shift in
prior thinking among participants, where most population health
analyses undertaken did not have a comparison group. A second
recurring challenge was identifying data sources which track both
intervention and control groups, as well as detail causal mechanisms
involved.
Of the original eight countries that attended the March 2017
workshop, five countries completed a total of six studies. Two
studies were excluded from peer-review, rejected by the series
editors. Mainly these failed to go beyond traditional descriptive
analyses. Four studies were sent to external peer-review with a rec-
ommendation to publish in this series, with the understanding that
they were part of a pragmatic approach to building capacity on
natural experiments.
Natural experiment studies
Originally, the proposed natural experiment studies included
alcohol, tobacco and nutrition interventions, but some of these
could not be developed due to inadequate data.
Three of the studies that were completed in this iteration focussed
on tobacco and one on trans-fats. Together they highlighted both
the promise and the pitfalls of implementing natural experiment
designs within a ministry of health:
 Austria examined the impact of a trans-fat ban introduced in
2009 on cardiovascular disease outcomes. To create a
comparison group, it employed a synthetic control method,
which creates an ‘artificial Austria’ based on data from
otherwise similar OECD countries. This replicated and
extended the design of an earlier natural experiment in
Denmark.8 It found no clear evidence that the 2009 legislation
improved CVD outcomes. However, several limitations make it
difficult to draw firm conclusions, including a synthetic control
that was poorly matched by characteristics for which there was
no data, and gaps in the data during the period studied making a
detailed time-series analysis difficult. In the short–term, it may
be challenging to attribute a health outcome (such as CVD
deaths) to the natural experiment. This remains a useful paper
that might point towards the need for both incorporating long-
term evaluations into such interventions and ensuring there is a
multi-faceted and whole system approach to national CVD
prevention and wider NCD control.
 Romania evaluated two consecutive sharp increases in tobacco
taxation in 2009 (by 28%) and in 2010 (by 16%) on potential
tobacco smuggling, hypothesizing that those regions bordering
on other countries might have greater risks from illicit tobacco
trade, so mitigating the health benefit of tax rises. This argument
is often used in tobacco-funded research to undermine the case
for taxes on tobacco consumption. Across the whole country,
deaths from smoking attributable diseases declined over the
study period, with steeper declines around the two years of tax
hikes. Importantly, and in contrast to the fears noted above,
there was no significant variation between regions within
Romania. The study did have several limitations: the study
period is short (2009–15) and this prohibits a rigorous pre-inter-
vention trend analysis; and the study is unable to account for the
varied and asymmetrical relationships between tax increases, the
impact on smoking prevalence, and the impact on smoking-
related hospitalizations, which are hard to account for when
using ecological data. However, this is a timely and important
paper that contributes to the evidence for national governments
to support tobacco taxes and stand firm against tobacco
counterarguments of illicit trade.
 The Russian team examined how Russia’s 2013 comprehensive
Tobacco Control Law altered cardiovascular morbidity and
mortality using a synthetic control design. They find evidence that
hospital discharges for acute circulatory diseases were lower than
expected after the reform, implying an associated benefit, but the
impact on mortality rates from circulatory diseases was less clear.
Again, residual confounders may explain the decline in the outcome
because hospital discharges are not solely driven by tobacco. These
make attributing the beneficial findings directly to the legislation
difficult. However, there is a clear positive association and this
study exploits an unusual opportunity in the evaluation of NCD
control because Russia’s Tobacco Control Law presents a compre-
hensive, large scale and discrete intervention, rather than the
iterative approach often taken in other settings. This is a useful
contribution to the body of natural experiment studies for the
evaluation of NCDs and takes another step towards demonstrating
the beneficial impact of comprehensive tobacco control.
 The Turkey team conducted a time-series analysis spanning the
period 1960–2016, measuring cigarette consumption. They
estimate whether the trend in consumption changes dramatically
after key policy reforms and supplement this with an analysis of
the political discourse surrounding these reforms. Tobacco con-
sumption increased with the entrance of multinational
companies in Turkey but fell after the introduction of a
national tobacco law in 1996. Policy discourse clearly shifted
over this period, demonstrating a change in the political will to
control tobacco consumption. However, the study does not fully
unpack the causal mechanisms between policy change and the
crude tobacco consumption trends. While the discourse analysis
is an illuminating addition to the tobacco trend analysis, it is
limited to only official notes from the legislature, rather than
looking as well at other media. Despite these remaining
concerns, the study presents an elegant and innovative use of
two methodologies, and demonstrates some of the political mo-
tivations and priorities influencing effective tobacco control. This
approach contributes to the natural experiment literature and
offers a good approach to contextualizing natural experiment
studies.
The learning
Looking ahead, we learnt three major lessons for improving evalu-
ations of public health interventions:
 Team structure: Most teams comprised a policy lead, a statisti-
cian, and a report writer. In most cases, it was simply asking too
much in the time allocated to the project for policy leads to
become familiar with the types of statistical analysis necessary
to implement most natural experiment methods. Writing up
the research is also a time-consuming process and other
responsibilities often encroached on the project, making it
difficult to find dedicated time to turn preliminary results into
a finished article.
 Review and shared learning: A more formal inter-team review
process might have strengthened the capacity building and
shared learning throughout the project. Asking teams to review
and comment on the work of others would have provided a
unique insight into how each team was tackling challenges,
which in many cases were similar. This would have allowed par-
ticipants to learn from the strengths and limitations in the work
of others to inform their own work.
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 Earlier identification of data: We began this iteration of the
project with a workshop on natural experiment methods in
which we outlined the main research designs and helped teams
develop study designs. However, this then became largely
divorced from questions regarding the suitability of available
data. We lost momentum in the project because it quickly
became clear that some of the proposed designs were not
feasible because of available and appropriate data. Remote
contact in the first instance may have allowed the teams to
identify more feasible natural experiments and scope appropriate
data before attending the more intensive face-to-face workshop
focussed on analyzing the data.
An ideal next step in this process would be to support countries to
start the design stage of a natural experiment study ahead of the
implementation of the public health intervention. This has been
achieved by CEDAR in the case of the UK sugary drinks tax levy.9
However, this approach will be difficult especially in the context of
some of the countries where capacity building is most important. In
which case, addressing these three major lessons for future iterations
of the exercise would be a priority.
Conclusion
Natural experiment study designs are increasingly employed in
academic research to shed light on how policy interventions affect
health, but remain much less common among practitioners of
various kinds, including within health ministries. We argue that,
given our experience, some level of natural experiment evidence
should be mandatory in NCD prevention interventions.
Our initiative shows the potential and promise of a straightfor-
ward programme to upgrade the quality of evidence and evaluation
routinely collected at health ministries across the European Region.
There are several directions for future capacity-building
programmes. One is to look to the future. Rather than retrospect-
ively design studies, after the policies have been implemented, is to
work closely with policymakers during the planning and roll-out. In
this way, through minor tweaks in the policy or programme, pol-
icymakers and public health practitioners can better learn in real-
time the live impact and identify gaps in successful implementation.
Policymakers could, e.g. stagger the roll-out of the intervention so
that some areas of the country receive it before others.
Another is to begin to think of all policies as real-world natural
experiments which can be evaluated. This involves a critical step for
those in health ministries to collect data on potential comparison or
control groups. This provides critical evidence on the science of
implementation. For example, examining whether trans-fat bans in
Austria have the same impact on health as bans on trans-fat
elsewhere may help reveal gaps in implementation or other real-
world conditions that modify the policies’ success or failure.
Similarly, replicating whether tobacco control in Russia delivers im-
provements in health creates the evidence-base necessary to protect
health gains from future efforts that may seek to weaken tobacco
control. The last few years have seen social security systems scaled
back in many countries and a more robust evidence base on the
health effects of welfare retrenchment may strengthen the case to
protect social protection systems.
Finally, it is important to acknowledge the limitations of these
studies, as with all observational designs. Evaluations in specific
settings may not be generalizable and be contingent on factors
that are assumed rather than explicitly modelled. A focus on
endpoint health and disease outcomes may not always be possible,
and proximal impacts or implementation indicators may better serve
to assess the value of natural experiments. The best natural experi-
ments often involve multiple methods and acknowledge that policies
tend to have nuances in implementation across all locations, despite
what the formal expectations may have been. Qualitative or ethno-
graphic approaches combined with process tracing can provide
much needed insight into how policies have been implemented
and whether the experience on the ground may partially explain
outcomes. Where it is not possible to find an appropriate control
group, there is still an important role for more traditional econo-
metric or epidemiologic methods.
The public health community has long committed itself to deepen
the understanding of what works, where and why. Natural
experiment study designs are a powerful tool to do so. Extending
it to public health settings across the WHO European Region,
building on the insights from our first attempt to do so here, is a
good place to start.
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